Innovative Research Award
Chalton Manengu
Southwest University, China
Chalton Manengu is a researcher affiliated with Southwest University, China, whose documented scholarly profile includes research activity in the area of cerebral ischemia-reperfusion. The research profile records 2 documents, 18 citations, and an h-index of 2 in the supplied Scopus-indexed record. These indicators provide a bibliometric context for evaluating the researcher’s scholarly contribution and emerging research impact. [1]
Abstract
The Innovative Research Award profile for Chalton Manengu recognizes an emerging research record associated with Southwest University and the scientific field of cerebral ischemia-reperfusion. Cerebral ischemia-reperfusion research examines the biological consequences of restoring blood flow following an ischemic event and encompasses molecular, cellular, physiological, and therapeutic dimensions. Reperfusion is essential for tissue recovery but may also initiate secondary cellular and inflammatory processes that influence neurological outcomes. [2]
Keywords
Cerebral ischemia-reperfusion, ischemic brain injury, reperfusion injury, neuroprotection, cellular mechanisms, oxidative stress, neuroinflammation, cell biology, translational neuroscience, Innovative Research Award, Southwest University, Chalton Manengu.
Introduction
Cerebral ischemia-reperfusion is a complex biological process in which restoration of cerebral blood flow after ischemia can produce both beneficial and adverse effects. Although reperfusion is necessary to restore oxygen and nutrient delivery, the transition from ischemia to reperfusion can involve oxidative stress, inflammatory signaling, mitochondrial dysfunction, blood-brain barrier disruption, and neuronal injury. These processes have made ischemia-reperfusion an important area of investigation in neuroscience and cellular biology. [2] [3]
Research Profile
The supplied researcher information places Chalton Manengu at Southwest University in China and identifies cerebral ischemia-reperfusion as the principal subject area. The associated Scopus author identifier is 59130694500. The recorded publication metrics are 2 documents, 18 citations, and an h-index of 2. Bibliometric data should be interpreted as indicators of scholarly visibility rather than standalone measures of scientific quality. [1][4]
Research Contributions
The available information supports characterization of the researcher’s contribution primarily through the subject-area focus and documented scholarly record. Cerebral ischemia-reperfusion research has broad relevance to cellular neuroscience because ischemia and subsequent reperfusion can alter redox balance, inflammatory pathways, mitochondrial activity, cellular signaling, and tissue homeostasis. [3] [2]
Publications
The supplied Scopus profile records 2 documents associated with the researcher and 18 citations. Because complete publication titles, journal information, publication years, and DOI identifiers were not supplied in the source data, individual publications are not attributed here without independent bibliographic verification. The Scopus author profile provides the appropriate source for reviewing the indexed publication record. [2] [4]
Research Impact
The supplied bibliometric profile reports 18 citations from 2 documents and an h-index of 2. These figures indicate that the indexed work has received measurable scholarly attention. Citation counts, however, vary according to database coverage, publication age, field-specific citation practices, and indexing differences. They should therefore be considered alongside qualitative evidence of originality, methodological quality, scientific influence, and reproducibility. [1]
Award Suitability
The Innovative Research Award profile is relevant to Chalton Manengu based on the supplied alignment between the researcher’s subject area and contemporary cell-biological investigation of cerebral ischemia-reperfusion. The subject involves cellular mechanisms that are central to understanding ischemic injury and subsequent tissue responses. [2]
Conclusion
Chalton Manengu of Southwest University, China, is presented in this academic recognition profile as a researcher working in the area of cerebral ischemia-reperfusion. The supplied Scopus information records 2 documents, 18 citations, and an h-index of 2. The research area has established importance within cellular neuroscience because ischemia-reperfusion involves interconnected mechanisms affecting neuronal, vascular, metabolic, inflammatory, and molecular processes. [1] [4]
External Links
References
- Elsevier. (n.d.). Scopus author details: Chalton Manengu, Author ID 59130694500. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=59130694500
- C Manengu, CH Zhu, GD Zhang, et al. (2024). HDAC inhibitors as a potential therapy for chemotherapy-induced neuropathic pain.
https://link.springer.com/article/10.1007/s10787-024-01488-x
- C Manengu. (2026). Bisdemethoxycurcumin attenuates sciatic nerve damage in Vincristine-induced Neuropathic Pain Mice.
https://europepmc.org/article/ppr/ppr1207864
- C Manengu, CH Zhu, GD Zhang, et al. (2025). Metabotropic glutamate receptor 5: a potential target for neuropathic pain treatment.
https://www.benthamdirect.com/content/journals/cn/10.2174/1570159X23666241011163035